(*) EU CE Mark Date: 2021. 08.19.
(*) USA Approval Date: 2021. 03.26
>4 Lines of Therapy Including>
CAR T Cell Therapy
Companies
Generic Name>Idecabtagene Vicleucel
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 5
Patent>UpDate: 2021. 03.23
TM
TM Web-Site